How Does HeartFlow's AI Analyze Your Heart Scan? | Dr Campbell Rogers | EP#426
Dr. Campbell Rogers explains HeartFlow's AI analysis process for heart scans, emphasizing that the company assesses image quality first, rejecting approximately 2-3% of scans that are too fuzzy. He highlights that scanner type, procedure techniques, and medications used at each site significantly impact image quality and the ability to track disease progression over time.
Summary
HeartFlow's AI analysis begins with a critical image quality assessment to ensure scans are sharp enough for detailed AI analysis. According to Dr. Rogers, approximately 97% of images meet the quality threshold for analysis, while the remaining 2-3% are rejected because they are too fuzzy or unclear to provide reliable results.
Dr. Rogers emphasizes that the specific equipment and techniques used at each imaging site make a meaningful difference in scan quality. Each cardiac imaging facility uses its own unique scanner and has its own unique procedures, protocols for scanner operation, and medication administration practices. HeartFlow invests considerable time and resources in working with CT imaging technology to optimize image quality across different sites.
When comparing scans from the same patient over time to assess disease progression, scanner consistency becomes particularly important. Using the same scanner and the same technique for both the initial and follow-up scans improves the reliability of comparisons and the ability to accurately determine whether coronary artery disease has worsened, improved, or remained stable.
Key Insights
- HeartFlow rejects approximately 2-3% of heart scan images because they are too fuzzy or lack sufficient clarity for detailed AI analysis
- Each cardiac imaging site operates with its own unique scanner, procedure protocols, and medication administration practices, which impacts image quality outcomes
- HeartFlow dedicates significant resources to optimizing CT imaging technology to standardize and improve image quality across different sites
- Using the same scanner and technique for repeat scans in the same patient is important for accurately comparing disease progression over time
- Scanner consistency and procedural standardization are critical factors in determining whether a patient's coronary artery disease has worsened, improved, or remained unchanged
Topics
Transcript
[0:00] How does heart flow perform analysis and how important is the machine that's used for the scan? >> The first thing we do is we do an assessment of image quality. That means images are sharp enough to do our detailed AI analysis. The images are good enough about a little more than 97% and the other two or 3% we don't provide an analysis is the images are just too fuzzy. To your question about the technique at the site, it does make a difference. Each site has its own unique scanner. They have their own unique [0:30] procedure, how the scanner is used, what medications are given. We at HeartFlow spend a lot of time working with…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Proof with Simon Hill
Cannabis & Sperm Quality: What the Research Actually Shows | EP#431
Cannabis use negatively impacts male fertility through multiple mechanisms including reduced sperm production, quality, and motility, with a dose-response relationship where daily use is considered problematic. Partners of cannabis users experience higher miscarriage rates, and IVF outcomes show lower embryo development rates in men who use cannabis, though the speaker advocates for moderation rather than absolute prohibition.
Can You Actually Reverse Liver Scarring? [Expert Explains] | EP#436
Liver fibrosis and scarring, previously thought to be irreversible, can actually be reversed even in advanced stages of steatotic liver disease. The liver has enormous regenerative potential and can recover from significant damage caused by alcohol or obesity, offering hope that early intervention can restore normal liver function.
Why Lower ApoB Longer Reduces Heart Disease Risk? | T. Dayspring & D. Soffer | EP#430
ApoB is established as a driver of atherosclerosis based on multiple types of evidence including clinical trials, observational studies, and genetic data. Lower ApoB levels for longer periods reduce heart disease risk, with clinical evidence showing continued cardiovascular benefit even when LDL-C is reduced from 70 to 15 mg/dL.
Do You Really Need Surgery for a Shoulder Tear? | Howard Luks | EP#438
Most joint and tendon pain in adults stems from lack of support, training, and proper loading rather than injury. Imaging often reveals age-related changes like labral tears that are normal findings over age 40-45 and don't necessarily require surgery, despite what social media doctors claim.
How Microplastics, Phthalates & PFAS May Affect Early Development & How to Reduce Exposure | EP#429
The episode discusses how microplastics, phthalates, and PFAS chemicals pose significant risks to child development during the first thousand days of life, with evidence showing specific harms like impacts on male fetal genital development and premature birth. The speaker emphasizes that systemic change through government regulation is necessary, while offering practical individual strategies to reduce exposure, primarily through avoiding heating food in plastic containers and switching to glass, steel, or natural materials.